Impact of the COVID-19 Pandemic on Health Care-Associated Infections and Antimicrobial Resistance in an ICU: A Comparative Three-Period Study.

Publication date: Aug 11, 2026

Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) are significant problems, especially in intensive care units (ICUs). We evaluated HAI rates, causative pathogens, resistance profiles, and antibiotic consumption retrospectively in a tertiary ICU across three 2-year periods-pre-pandemic period (PreP), pandemic period (PanP), and post-pandemic period (PostP)-to assess the impact of the COVID-19 pandemic. Antibiotic consumption was expressed as defined daily dose (DDD) per 1,000 patient days. The highest infection incidence rate and density were in PanP. Despite lower invasive device use, PanP had a higher rate of catheter-related bloodstream infections (BSIs). The most frequent pathogen across periods was Acinetobacter spp. , although its rate declined in PostP. Gram-negative bacteria resistance rates to piperacillin-tazobactam, carbapenem, and aminoglycoside were highest in PanP. Resistant pathogen and resistant infection rates were lower in PostP, and resistant infections were less frequent in PostP than in PanP (OR: 0. 371; 95% CI: 0. 216-0. 637; p

Concepts Keywords
antimicrobial resistance
COVID-19
healthcare-associated infections
infection control
intensive care unit

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH Infections
disease MESH DDD
disease MESH bloodstream infections
drug DRUGBANK Piperacillin
drug DRUGBANK Tazobactam
disease MESH Healthcare-associated pneumonia

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *